New Director

Perspectum Announces Executive Leadership Changes

Jan 7

/

This is some text inside of a div block.

Perspectum Announces Executive Leadership Changes

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat. Aenean faucibus nibh et justo cursus id rutrum lorem imperdiet. Nunc ut sem vitae risus tristique posuere.

Perspectum Announces Executive Leadership Changes

Perspectum and Avant Santéannounce strategic partnership to strengthen quantitative imaging for metabolic and liver research in Mexico and Latin America

Perspectum and InHealth announce national diagnostics partnership to boost Oxford CDC capacity and widen access to advanced MRI across the UK

New analysis shows corrected T1 (cT1) is the most appropriate diagnosis and monitoring tool for widespread adoption of resmetirom treatment in the United States

UK Biobank Completes World’s Largest Human Imaging Study

Marea Therapeutics Publishes Phase 2 Trial Results in The Lancet

Major Study Shows Liver Health Measured with cT1 Predicts Clinical Outcomes

New Multinational Study Shows MRI is Cost-Effective in the Diagnosis and Management of Steatotic Liver Disease

Perspectum Awarded New FDA Grant to Evaluate Biomarker for Rare Disease Drug Development

CoverScan, Perspectum’s multi-organ MRI technology, has been nominated for the 2024 Prix Galien USA award for Best Digital Health Solution.

New Published Data Show Reproducibility and Utility of Perspectum’s MRI in Patients With Metabolic Liver Disease

Dr Rajarshi Banerjee joins Amrita Sarkar, Principal Healthcare and Life Sciences Startups Business Development manager in this episode of the AWS Health Innovation Podcast.

LITMUS Project – LiverMultiScan™ included in ground-breaking €34 million project to develop better test for liver disease

LiverMultiScan™ Receives FDA 510(k) Clearance for Version 2 of Medical Device

LiverMultiScan™ analysis of UK Biobank indicates as many as 1 in 8 adults may have non-alcoholic steatohepatitis (NASH)

Analysis of Biobank data shows 1 in 8 adults may have NASH

Multiparametric liver MRI could refine the way we currently approach testing of therapeutic candidates in preclinical models

Biotech Investors Should Consider The Four Horsemen

New paper released from the University of Nottingham on quantitative T1 mapping in liver disease

Good diagnostic accuracy with non-invasive Multiparametric MRI across a range of liver disease severity

Large population imaging study reveals utility of LiverMultiScan’s cT1 measure

LiverMultiScan receives regulatory clearance for clinical use in Australia

NASH-FX trial shows excellent reproducibility of cT1 as a non-invasive biomarker of liver health

LiverMultiScan receives regulatory clearance in Singapore

Liver Physicians Pioneering National Digital Health Strategy with GE Healthcare

Predicting Clinical Outcomes with Multiparametric MRI Featuring Liver cT1 Equal to Biopsy, According to Research Presented at The Liver Meeting® 2018

Data released at The Liver Meeting ® 2018 Shows MRCP+ is a Promising Non-Invasive Technology for Quantitative Evaluation of Hepatobiliary Diseases

Perspectum Diagnostics Showcases Quantitative MR-Based Biomarkers for Liver and Hepatobiliary Health at RSNA

Perspectum Diagnostics Named in Top 100 Fastest Growing Companies

Collaboration to Advance Development of Therapies for Patients with Serious Liver Disease

New data reveals prevalence of iron overload in UK Biobank population

FDA Clearance for Perspectum’s Digital Biliary Tree Viewer, MRCP+

Perspectum Diagnostics chosen as winners of Red Herring’s Top 100 Europe Awards 2019

Perspectum Diagnostics Named Fastest Growing UK-based Life Science Company

New AI-Powered Body Scans to Improve Type 2 Diabetes Patient Stratification

Multi-Parametric MRI Can Predict Clinical Outcomes, New Data Reveals

New Quantitative Biliary Imaging Technology Could Transform PSC Clinical Practice

Reliable, Repeatable, Reproducible: New Data Demonstrates Multiparametric MRI’s Ability to Characterise Liver Tissue

US Clinical Network to Support Liver Disease Patient Trials

New Study Using Cutting Edge MRI Technology Identifies Genetic Causes of High Liver Iron

Perspectum and ProPath Announce Partnership

New Diagnostic Tool for Biliary Disease Being Assessed for NHS

FDA Awards Grant for LiverMultiScan to help NASH patients

Perspectum announces partnership with Precious Medical Centre

Revolutionizing diagnostics in autoimmune liver disease with Perspectum’s quantitative imaging techniques

Seeing and measuring hepatobiliary disease using artificial intelligence, presented by Perspectum at RSNA 2019

Perspectum employee Lis Pickles receives prestigious Royal Commission for the Exhibition of 1851 Industrial Fellowship

Healthy Eating and Increased Physical Activity Paramount to Treatment of Non-Alcoholic Fatty Liver Disease

Perspectum & Stand-Up MRI of Miami Announcement

Unrivalled quantitative MRI of the biliary tree could be the next generation in diagnosis and monitoring for patients with biliary disease

Video: An FDA-Cleared Non-Invasive Test for Liver Disease

Press Release: Gene identified as a potential target for drugs to prevent liver disease

Press Release: 3T Radiology & Research and Perspectum Announce Partnership

COVID-19; Inflammation and Obesity Links

Press Release: Perspectum Closes $36M Financing Round co-led by Blue Venture Fund and HealthQuest Capital

How We Aid Doctors in the Diagnosis of Liver Disease

Perspectum Launches the First COVID-19 Recovery Study

Your Questions Answered: Clinical FAQ’S

Guidance for trials using MRI during COVID-19

Provider Education Series

Did you know that more than half of your patients with type 2 diabetes have NAFLD?

Going Beyond the Biopsy & Adopting Noninvasive Technologies

High liver fat associated with a higher risk for severe COVID-19

Perspectum partners in a multimillion pound research project (ID-LIVER) to help prevent patients from developing liver cancer

Perspectum Launches Multi-Site NASH Study to Accelerate Patient Enrollment

Perspectum expands AI and imaging CRO portfolio with Cardiac Imaging

The link between type 2 diabetes and liver disease: can screening for NAFLD reduce liver-related mortality?

Quantitative MRI; a game changer for identifying the chronic liver disease patients most at risk of poor clinical outcomes

Meet the team: Improving Outcomes through Customer Success

Multiparametric MRI: bridging the diagnostic gap for liver disease

Perspectum Partners with UT Southwestern Medical Center on Dallas Heart & Minds Study

Beyond the Biopsy

New non-invasive MRI biomarker for liver disease could cut costs for drug trials

How to Choose an Imaging Provider for Your Clinical Trial

Perspectum and UK Biobank help to uncover genetic marker associated with fatty liver disease

New monitoring tool could be a positive change on the horizon for children with autoimmune hepatitis

Join a Patient Registry

Perspectum Releases New Whitepaper on The Cost-Effectiveness of Including Imaging in Phase 3 NASH Trials

Perspectum launches new multiorgan imaging offering, Atlas®, for pharma sponsors at The Liver Meeting Digital Experience™ (TLMdX) 2020